In the present study, the suppressive effect of delphinidin on HER-2 positive breast cancer cells was shown to occur through the mTOR pathway; thus, the proliferation inhibition and autophagy induced by delphinidin might be attributable to the same pathway. Here, MTOR is linked to breast cancer.